163 related articles for article (PubMed ID: 7532652)
1. Recurrent gestational trophoblastic disease following in-vitro fertilization.
Tanos V; Meirow D; Reubinoff BE; Anteby SO
Hum Reprod; 1994 Nov; 9(11):2010-3. PubMed ID: 7532652
[TBL] [Abstract][Full Text] [Related]
2. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
[TBL] [Abstract][Full Text] [Related]
3. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
4. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
5. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
[TBL] [Abstract][Full Text] [Related]
7. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
8. Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review.
Nobuhara I; Harada N; Haruta N; Higashiura Y; Watanabe H; Watanabe S; Hisanaga H; Sado T
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):588-593. PubMed ID: 30122584
[TBL] [Abstract][Full Text] [Related]
9. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system involvement in gestational trophoblastic neoplasia.
Altintaş A; Vardar MA
Eur J Gynaecol Oncol; 2001; 22(2):154-6. PubMed ID: 11446484
[TBL] [Abstract][Full Text] [Related]
11. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
[TBL] [Abstract][Full Text] [Related]
12. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
13. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
Cyriac S; Rajendranath R; Sridevi V; Sagar TG
J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
[TBL] [Abstract][Full Text] [Related]
14. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
15. High-risk metastatic gestational trophoblastic disease.
Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
[TBL] [Abstract][Full Text] [Related]
16. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
17. EMACO in high risk gestational trophoblast disease--the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia.
Quinn M; Murray J; Friedlander M; Steigrad S; Khoo S; Marsden D; Hammond I; Jobling T
Aust N Z J Obstet Gynaecol; 1994 Feb; 34(1):90-2. PubMed ID: 8053886
[TBL] [Abstract][Full Text] [Related]
18. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, dactinomycin, vincristine, and cyclophosphamide.
Gallion HH; van Nagell JR; Donaldson ES; Higgins RV
Gynecol Oncol; 1989 Jul; 34(1):98-100. PubMed ID: 2544491
[TBL] [Abstract][Full Text] [Related]
19. Gestational trophoblastic disease.
Hammond CB; Olt GJ
Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
[No Abstract] [Full Text] [Related]
20. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
